cytomedix inc (CMXI:OTC BB)

Executive Profile*

Background*

Dr. David F. Counts was the Director, U.S. Life Sciences Ventures at ANGLE Technology Ventures Limited. He joined the firm in 2005. Dr. Counts lead the firm’s efforts in life sciences, based in the Philadelphia office. He worked closely with the technology transfer staff at the Philadelphia area universities to help identify suitable technologies for commercialization and to create start-up ventures with the Ben Franklin Technology Partnership and other private investment ... organizations in the region. Prior to this, he was employed at Ben Franklin Technology Partners of Southeastern Pennsylvania joining in 2001 as the Director of Life Sciences, where Dr. Counts was responsible for developing the Innovation Partnership in addition to being responsible for obtaining corporate sponsors for the Nanotechnology Institute. Previously, he was an Associate Vice President of Assessment and Evaluation at Ben Franklin Technology Partners. Before this, Dr. Counts was the Director for Preclinical Research at Curative Technologies Inc. with responsibility for preclinical development studies. He helped found a company that developed and marketed products for skin care (Avogen). Earlier, Dr. Counts was also a faculty member at Washington State University and at the University of Vermont. He initiated research on skin aging at the Gillette Research Institute and later was employed at Lilly Research Laboratories and Marion Laboratories, working on anti-inflammatory compounds, peptide therapeutics and devices. Dr. Counts later worked to capture early stage university biotechnology discoveries. He has publications and patents in wound healing, immunology, and inflammation. Dr. Counts has participated in presenting commercial opportunities to corporations, negotiated research contracts, and served as a scientific liaison for commercial development. He is a Member of Life Sciences Technology Advisory Committee of Ben Franklin Technology Partners of Southeastern Pennsylvania. He did a postdoctoral fellowship at the Roche Institute of Molecular Biology. Dr. Counts received his B.S. from Tulane and Ph.D. in Molecular Biology from the Medical College of Georgia.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CMXI:US	$0.50 USD	0.00

COMPETITOR COMPENSATION